AimeeChristineTalleurMD

Pediatric Hematology & Oncology • Memphis, TN

Pediatric Hematologic Oncology

Assistant Professor and Fellowship Director; Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital

Join to view full profile

Dr. Talleur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Talleur's full profile

Already have an account?

Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105

Summary

Dr. Aimee Talleur is a pediatric hematologist/oncologist in Memphis, TN and is affiliated with St. Jude Children's Research Hospital. She received her medical degree from State University of New York Upstate Medical University and has been in practice 8 years. She specializes in pediatric hematologic oncology, with a focus on bone marrow transplantation and cellular therapy for high-risk malignancies.

Education & Training

St. Jude Children's Research HospitalBone Marrow Transplantation and Cellular Therapy, 2015 - 2017
St. Jude Children's Research HospitalPediatric Hematology/Oncology, 2012 - 2015
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Children's National HospitalResidency, Pediatrics, 2009 - 2012
SUNY Upstate Medical UniversityClass of 2009

Certifications & Licensure

TN State Medical License 2012 - 2025
DC State Medical License 2011 - 2012
VA State Medical License 2009 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia Start of enrollment: 2018 Jul 24
Active, not recruiting
Phase 1, Phase 2
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia Start of enrollment: 2024 Feb 14
Recruiting
Phase 1

Publications & Presentations

PubMed

EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy.
Dua'a Zandaki, Subodh Selukar, Yu Bi, Ying Li, Megan Zinsky
Blood Advances. 2025-01-28
Safety and Efficacy of High-Dose Memory CD45RODonor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation.
Mercedes Gasior Kabat, Ying Li, Victor Galán, Yasmina Mozo, Luisa Sisinni
Cytotherapy. 2024-12-01
2 citations
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.
Yonique Petgrave, Subodh Selukar, Rebecca Epperly, Swati Naik, Noel DeLos Santos
Pediatric Nephrology. 2024-08-01

External Links

St Judehttps://www.stjude.org/directory/t/aimee-talleur.html